Pharmaceuticals

Rising Prevalence Of Spinal Conditions Fueling The Growth Of The Market Due To Increasing Demand For Effective Pain Management Solutions Is Supporting Development Across The Facet-Joint Injection Market

May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Facet-Joint Injection Market Change Between 2026 And 2030?

The facet-joint injection market has witnessed substantial growth in recent years. Its value is projected to expand from $2.97 billion in 2025 to $3.18 billion in 2026, at a compound annual growth rate (CAGR) of 6.9%. This historical growth can be attributed to the prevalence of spinal degeneration, the incidence of arthritis, heightened awareness of pain management, the use of corticosteroids, and the increase in outpatient procedures.

The facet-joint injection market size is anticipated to undergo robust expansion in the coming years. This market is forecast to achieve a valuation of $4.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. The upward trend during the projected period stems from the aging population, a preference for minimally invasive treatments, the prevalence of chronic pain, the growth of ambulatory care, and the use of imaging-guided procedures. Noteworthy trends for the forecast period encompass an increasing need for minimally invasive pain interventions, broader application in managing chronic back pain, the rise of outpatient pain clinics, the embrace of image-guided injection methods, and the expansion of ambulatory surgical centers.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

What Are The Main Drivers Accelerating The Growth Of The Facet-Joint Injection Market?

The facet-joint injection market is projected to expand due to the increasing incidence of spinal conditions and persistent back discomfort. These issues encompass chronic ailments affecting the spine, such as disc degeneration, arthritis, or nerve compression, which lead to ongoing pain, restricted movement, and a diminished quality of life. The growing occurrence of spinal diseases and chronic back pain results from inactive lifestyles and poor posture habits, prompting individuals to seek effective, low-disruption treatments that alleviate persistent discomfort and restore functional movement. Facet-joint injections provide relief for those suffering from spinal diseases and chronic back pain by reducing inflammation and pain in the spine. For instance, in May 2023, according to Spinal Cord Inc., a US-based non-profit resource center, in 2023, around 18,000 new spinal cord injury (SCI) cases are reported annually in the United States, with an estimated 302,000 individuals currently living with spinal cord injuries nationwide. Consequently, the rising prevalence of spinal diseases and chronic back pain is driving the growth of the facet-joint injection market.

What Are The Core Segment Classifications In The Facet-Joint Injection Market?

The facet-joint injection market covered in this report is segmented –

1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints

3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone

2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine

3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations

Which Trends Are Expected To Shape The Facet-Joint Injection Market?

Leading companies in the facet-joint injection market are concentrating on developing innovative products, such as facet fusion systems, to deliver more prolonged relief and enhance treatment outcomes. Facet fusion systems are medical devices specifically designed to stabilize and fuse the facet joints of the spine by promoting bone growth between neighboring vertebrae. For example, in March 2025, Aurora Spine Corporation, a medical device company based in the US, declared that its newest product, the AEROTM Facet Fusion System, had achieved 510(k) clearance from the U.S. Food and Drug Administration (FDA). This system incorporates a titanium plasma spray coating to improve osseointegration and fusion potential. It also supports multiple implant sizes to suit varied patient anatomies and features radiolucent instrumentation to improve intraoperative visibility. These combined features aim to boost procedural efficiency and achieve better long-term results in treating chronic back pain caused by facet joint disorders.

Which Industry Players Are Present In The Facet-Joint Injection Market?

Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation

Access The Complete Facet-Joint Injection Market Report:

https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

Which Region Has The Strongest Presence In The Facet-Joint Injection Market?

North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Facet-Joint Injection Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

Browse Through More Reports Similar to the Global Facet-Joint Injection Market 2026, By The Business Research Company

Self Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Facial Injectable Market Report 2026

https://www.thebusinessresearchcompany.com/report/facial-injectable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795